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Consensus genotypeComparisons of targeted genotyping chips to ready-made chips are important because targeted chips are
suitable for ﬁne-scale association mapping with a reasonable cost. Genotypes produced by the Affymetrix
Targeted Genotyping (TG) 25K, Affymetrix 500K, and Illumina 550K arrays for regions on chromosomes 2
and 7 of 90 individuals were assessed to investigate genotype accordance between the platforms. The
common SNPs in TG the Affymetrix and Illumina arrays showed similar genotype accordance. The
consistency rate of the Illumina array to consensus genotypes, i.e., identically called by more than two
platforms, was the highest, and that of the Affymetrix array was the lowest. The TG array data showed high
accordance and reasonable consistency between platforms.
© 2009 Elsevier Inc. All rights reserved.Introduction
Recent developments in genome-wide assays are accelerating the
study of human health and disease. The use of high-throughput
genotyping technologies, such as the Affymetrix 500K array and the
Illumina HumanHap 550K beadchip, has driven down the costs of
genome-wide association (GWA) and linkage studies. In addition, the
Affymetrix custom-made GeneChip® Targeted Genotyping (TG) system
is suitable for complex genetic studies with ﬁne resolution in candidate
regions or genes. The TG system uses the molecular inversion probe
(MIP) assay that enables genotyping of up to 25K SNPs in a single assay
allowing for highly accurate and cost-effective ﬁnemapping of targeted
SNPs [1]. Forexample, a previous study showed thatAffymetrix Targeted
Human Drug Metabolizing Enzyme and Transporter (DMET) assays
could provide an understanding of pharmacokinetic responses to drugs
[2]. Another case-control study using the TG 3K chip array found that
several polymorphisms in a major antioxidant enzyme were signiﬁ-
cantly associated with osteonecrosis [3].m), honghee.won@gmail.com
park@samsung.com (J.H. Park),
samsung.com (S. Kim),
ll rights reserved.Genotyping errors, however, can lead to fallacious results in associa-
tion or linkage studies. Previous reports have highlighted the importance
of detecting and evaluating genotyping errors since inaccurate datamight
reduce the power of detecting true positive associations [4,5] or linkage
disequilibrium (LD) [6,7]. Therefore, evaluating the genotyping accuracy
of the current SNParrayswill assist in choosing anappropriate technology
to achieve the goal of each study. Although previous reports have
evaluated the accordance of genotypes between the Illumina and
Affymetrix platforms [8,9], no report has compared all three platforms
(Illumina, Affymetrix, and TG arrays). Moreover, a systematic evaluation
of the TG array accuracy has not been performed.
In this study, we compared genotypes for common SNPs using three
platforms: the TG 25K, Affymetrix 500K, and Illumina 550K arrays. We
selected regions on chromosomes 2 and 7, which have been reported to
be signiﬁcantly associated with various complex diseases [10,11]. We
identiﬁed 2536 common SNPs (Set A=Subset I+II) between the TG
and Affymetrix arrays and 4090 SNPs (Set B=Subset I+III) between
the TG and Illumina arrays (Fig.1).We also used 775 common SNPs (Set
C=Subset I) among the TG, Affymetrix, and Illumina arrays for the
cross-platform comparison. To compare genotyping accuracy between
the Affymetrix and Illumina arrays, we used the TG 25K as a reference
array. After quality control (QC) (for details, seeMaterials andmethods),
2436 common SNPs (Set Aq=Subset Iq+IIq) remained between the TG
and Affymetrix arrays, 3982 common SNPs (Set Bq=Subset Iq+IIIq)
remained between the TG and Illumina arrays, and 757 common SNPs
(Set Cq=Subset Iq) remained between the TG, Affymetrix, and Illumina
Fig. 1. Selection of common SNPs analyzed among the three platforms. Subset I denotes
the common SNPs determined from all three platforms (TG, Affymetrix, and Illumina
arrays). Subset II denotes the common SNPs between the TG and Affymetrix arrays,
excluding Subset I. Subset III denotes the common SNPs between the TG and Illumina
arrays, excluding Subset I. Set A is the sum of Subset I and II and this set enables
comparisons of SNPs between the TG and Affymetrix arrays. Set B is the sum of Subset I
and III and this set allows comparisons of SNPs between the TG and Affymetrix arrays.
Sufﬁx q indicates QC SNPs. The numbers in parentheses are QC SNPs.
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the deﬁned sets.
Results
Analysis of genotype accordance between platforms
Three types of proportions, genotype–genotype accordance, geno-
type–genotype discordance, and no-calls, were compared between the
two platforms. Accordance indicates the same genotypes called by two
platforms, discordance indicates different genotypes between two plat-
forms, and no-calls indicate genotyping fails at least one platform. The
accordance rate between the TG and Illumina arrays (Set B) was slightly
higher than the rate between the TG and Affymatrix arrays (Set A)
(Table 1). Detailed comparisons of genotypes produced by the TG,
Affymetrix, and Illumina platformswere shown in Supplementary Table 1.
94.86% (216,506 of 228,240) of total calls in Set A (2536 SNPs×90
samples) were accordant, and 95.84% (352,767 of 368,100) of total
calls in Set B (4090 SNPs×90 samples) were accordant. When no-calls
in either platform were excluded, the accordant rate increased
substantially in both sets. The accordant rate increased to 99.22% in
Set A and 99.36% in Set B. As expected, we observed a high accordant
rate after performing QC. 97.40% of calls in Set Aq (2428 SNPs×90
samples) were accordant, and 98.43% of calls in Set Bq (3982 SNPs×90Table 1
Genotype accordance between the TG, Affymetrix, and Illumina platforms.
Set Before QC
No. of
SNPs
No. of accordance
With no-calls Without no-calls
A 2536 216,506/228,240 216,506/218,414
(94.86%) (99.22%)
B 4090 352,767/368,100 352,767/355,224
(95.84%) (99.36%)
Set A represents common SNPs between the TG and Affymetrix arrays, and Set B represents
accordant genotypes and denominators indicate the total number of genotypes with or witho
two platforms.samples) were accordant. When no-calls were excluded, the accor-
dant rate was 99.15% in Set Aq and 99.31% in Set Bq.
Therewas a higher accordance between the two platforms for Set C
(99.39% between TG and Affymetrix arrays, and 99.73% between TG
and Illumina arrays) than for Set A and Set B because SNPs in Set C
were reﬁned after passing the QC ﬁlters in all the three platforms
(Supplementary Table 2 and Supplementary Text 1).
Analysis of discordance and no-call patterns between platforms
A particular pattern of discordances was observed (Supplementary
Fig. 1); most of the discordant pairs were pairs of homozygous
genotype and heterozygous genotype. There were a few occurrences
where one platform called a genotype as a homozygote and the other
platform called the genotype as the opposite homozygote (Supple-
mentary Text 2). The frequency of SNPs called with discordance
between platforms rapidly decreased in both sets as the number of
discordant genotypes increased (Supplementary Table 4).
Therewere different heterozygosity patterns between Set A and Set
B in the no-call distribution (Fig. 2). While no-calls of the Affymetrix
array were frequently called as homozygotes by the TG array, those of
the Illumina array were called as heterozygotes by the TG array.
We investigated genotyping accordance or discordance for Set A
and Set B by changing the threshold of call rate. Accordant pattern
varies according to the call rate. The accordant rate decreased slightly
as the call rate decreased from 100% to 80% and the rate rapidly
decreased as the call rate decreased from 80% to 0%. In contrast, the
discordant rate increased slightly as the call rate decreased from 100%
to 75–80% (Fig. 3). The accordant rate increased as the call rate
increased. This ﬁnding highlights the importance of the call rate
threshold in SNP array data and supports the idea that the QC of
genotype data can be guaranteed by adjusting the call rate threshold.
Evaluating consistency of platforms to consensus genotypes
To enable cross-platform comparisons, a consensus data set was
created. We deﬁned consensus genotypes as the genotypes identically
called bymore than two platforms. For example, if the TG array calls a SNP
genotype ‘A/A’, theAffymetrixarraycalls the sameSNPgenotype ‘A/A’, and
the Illumina arraycalls the sameSNPgenotype ‘A/A’ ordifferent genotypes
(‘A/B’, ‘B/B’, or no-call), ‘A/A’ is a consensus genotype. A consensus
genotype was considered unreachable when more than two platforms
showed no-calls or all three platforms called different genotypes.
Consensus genotypes were 99.93% of genotypes (69,703 of 69,750) in Set
C (775 SNPs×90 samples). In the QC data, it was 99.95% of genotypes
(68,098 of 68,130) in Set Cq (757 SNPs×90 samples). The ratio of
unreachable consensus genotypeswas 0.07% beforeQC and 0.05% after QC.
We evaluated consistency to the consensus genotypes for each of
the three platforms (Table 2). As the TG array had the largest no-call
rate (2.87%), the consistency rate to the consensus genotype was the
worst (96.92%). For the QC data, however, the consistency rate of the
TG array (99.08%) was higher than that of the Affymetrix array.After QC
No. of
SNPs
No. of accordance
With no-calls Without no-calls
2468 216,354/222,120 216,354/218,214
(97.40%) (99.15%)
3982 352,767/358,380 352,767/355,224
(98.43%) (99.31%)
common SNPs between the TG and Illumina arrays. Numerators indicate the number of
ut missing genotypes. The percentage in parenthesis indicates accordance rate between
Fig. 2. Relationship between heterozygosity ratio in one platform and no-calls in the other platform (Set A and Set B). The horizontal bar represents the heterozygosity ratio of
genotypes called by the TG array among the no-calls in the other platform. The heterozygosity ratio of the TG array was signiﬁcantly different between the Affymetrix and Illumina
array.
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rate of the TG array improved to 99.78% and the Affymetrix array
showed the worst performance at 99.63%. The Illumina array showed
the best performance regardless of the QC ﬁlters.Fig. 3. Relationship between accordant pattern and call rate of the TG, Affymetrix, and
Illumina platforms (Set A and Set B). “Accordance” denotes the same genotype between
the two platforms. “Discordance” denotes different genotype between the two
platforms and “No-call” denotes missing genotype in either of the two platforms. (A)
Accordance patterns for the TG and Affymetrix platforms (Set A) are shown by the call
rate. (B) Accordance patterns for the TG and Illumina platforms (Set B) are shown by the
call rate. On the same x-axis, the total percentage of the three patterns is 100%. For SNPs
passing call rate of 80% in Set A, the portion of accordant genotypes was 78.46% and that
of discordant genotypes was 2.91%, and no-call rate was 18.63%. For SNPs passing call
rate of 80% in Set B, the portion of accordant genotypes was 79.89% and that of
discordant genotypes was 6.32%, and no-call rate was 13.79%. This ﬁgure shows that the
number of accordant genotypes varies greatly depending on the threshold of call rate,
while that of the discordant genotypes varies only slightly.Materials and methods
DNA samples
The samples used for the study comprised 90 Korean healthy
subjects selected from cohort samples preserved at the Korean
National Institute of Health (KNIH) for subjects without a family
history of major diseases [12,13]. SNP sites were selected from dbSNP
database build 119 [14] after applying repeat masking. Approval from
the relevant ethic committees and informed consent from all
participating subjects were obtained by KNIH.
Region and SNP selection
For the TG array, SNPs were selected with an LD-based tagging
method using the pairwisemode of the Tagger software [15] and ethnic-
speciﬁc genotype data of Han Chinese in Beijing (CHB) and Japanese in
Tokyo (JPT) from the international HapMap database [16]. For the TG
array, SNPs were selected from regions on chromosomes 2 and 7,
including chr2: 10.0–31.7 Mb, chr2: 75.0–120.0 Mb and chr7:85.0–
115.0 Mb. The selected regions cover a wide area on the chromosome
and have many disease-associated genes. In the chr2: 10.0–31.7 Mb
(2p25.1–2p23.1) region, there are 197 genes and 86 disease genes
reported in the online Mendelian inheritance in man (OMIM) database
[17]. In chr2: 75.0–120.0 Mb (2p13.1–2q14.2), there are 482 genes and
86 disease genes reported in OMIM. In chr7: 85.0–115.0 Mb (7q21.11–
7q31.2), there are 315 genes and 14 disease genes reported in OMIM.
Genotyping
We used the Affymetrix GeneChip® Human Mapping 500K Array
Set (Affymetrix Inc, Santa Clara, CA, USA). Genomic DNA was isolated
from whole blood samples using the Wizard® Genomic DNATable 2
Consistency to consensus genotypes in the TG, Affymetrix, and Illumina platforms
(Set C).
Consistent
pattern to
consensus
genotypes
Consistency (%) in platforms
TG Affymetrix Illumina
Consistent 96.92 (99.08) 98.61 (98.64) 99.95 (99.95)
Inconsistent 0.21 (0.24) 0.37 (0.36) 0.02 (0.02)
No-calls 2.87 (0.69) 1.01 (1.00) 0.04 (0.04)
Total 100 100 100
Consensus genotypes are deﬁned as the same genotype called by more than two
platforms among three platforms. The numbers in parentheses are the QC data
excluding SNPs due to a low genotype frequency (b80%) and deviation from HWE
(Pb0.001). Consistency means that genotype in one platform was the same as the
consensus genotype. Inconsistency means that the genotype in one platform was
different from the consensus genotype.
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scanned individually using the GeneChip® Scanner 3000 7G under the
GeneChip® Operating Software (GCOS). The data was processed using
the Affymetrix Genotyping Analysis Software (GTYPE) with the
BRLMM calling algorithm. High-density oligonucleotide-based SNP
analysis was performed using an Illumina Inﬁnium whole-genome
genotyping Beadchip (Illumina Inc, San Diego, CA, USA). The
beadchips were processed for the single base extension reaction,
and then stained and imaged on an Illumina Bead Array Reader.
Normalized bead intensity data was obtained for each sample and the
Illumina Beadstudio software converted ﬂuorescent intensities into
SNP genotypes.
Genomic DNA was normalized to 150 ng/μl for genotyping on a
custom-designed 25K GeneChip Universal Tag Array with the
Affymetrix GeneChip Scanner 3000 7G MegAllele System (Affyme-
trix) based on Molecular Inversion Probe technology (ParAllele
Bioscience Inc, Santa Clara, CA, USA), as recommended by the
manufacturer. Data was processed using the GeneChip Operating
System version 1.3.0.031 (Affymetrix) and genotypes were deter-
mined using the Cluster Fit function of TrueCall Analyzer version
7.0.0.22. All genotypes were conﬁrmed by an operator for ﬁnal
genotype calls. The genotyping data in this study is available from the
Korean HapMap (KHapMap) Browser [18].
Data pre-processing
Because the allele designations were arbitrary, we assigned them
to the plus strand direction for our template. Major alleles of the TG
array were standardized by the Affymetrix or Illumina arrays. For an
undecided major allele, we set the major allele determined by the TG
array as the major allele. Joint distribution of genotypes was analyzed
by the use of standardized major alleles.
QC ﬁlters were performed to ensure high quality of the genotype
data, with each SNP tested for completeness (no-calls ≤20%) and
Hardy–Weinberg equilibrium (HWE) (PN0.001). Sufﬁx q denotes the
QC data.
Discussion
GWA studies using SNP chips are a major approach for discovering
genes contributing to complex diseases. Both the Affymetrix and the
Illumina arrays have been used to identify novel disease genes, and
the results have been mostly consistent across studies using different
platforms. When designing a GWA study, it is necessary to evaluate
and compare all available SNP chips and to select the most cost-
efﬁcient chip. Coverage of genes or regions of interest should also be
taken into account when selecting SNP chips. In our study, we
evaluated and compared three platforms: the TG 25K, Affymetrix
500K, and Illumina 550K platforms.
When two platforms (Set A: TG and Affymetrix; Set B: TG and
Illumina) make a genotypic call, the accordant rate between platforms
is as high (range 99.22–99.73%) as the Collaborative Study on the
Genetics of Alcoholism (COGA) data result (99.85%) [9]. DMET assays
using the TG array showed similar genotyping accuracy (99.8%) [2].We
observed a slightly lower genotype performance for the Affymetrix
array than for the Illumina array and this is a similar result to the COGA
data. For the SNPs in Set A and Set B, high accordance rates were
observed. For the QC data, the genotype accordance rates increased in
both sets. Moreover, common SNPs between all the three platforms
(Set C) had higher accordance than those between two platforms.
We also analyzed the trade-off between the no-call rate and
genotyping accuracy. A previous study examined the accuracy of
haplotype frequency estimation in the presence of no-calls [19]. In this
study, the authors suggested that the absence of up to 30% of data can
be tolerated. The Affymetrix and Illumina companies recommend that
the threshold of call rate is at least 85% [20,21]. In our analysis,however, the accordant rate decreased rapidly when no-calls
exceeded 20% of genotypes. This result suggests that the call rate
can be lowered up to 80% without signiﬁcantly sacriﬁcing quality.
Although the Affymetrix 500K and Illumina 550K arrays provide
the best genome coverage in Caucasians, they show insufﬁcient
coverage in non-Caucasian populations because their SNPs were
optimally designed for Caucasians [15,22]. Whereas ready-made SNP
chips have population-speciﬁc limitations, the TG array might provide
sufﬁcient coverage of regions of interest for non-Caucasian popula-
tions thereby facilitating complex genetic studies with ﬁne resolution
in candidate regions or genes. In previous reports, it was not possible
to judge which platform called correctly because only two ready-
made SNP chips were compared [8,9]. In contrast, we could deﬁne the
consensus genotype as the same genotype called by more than two
out of three platforms. In Set Cq, the TG array showed a high
consistency rate to the consensus genotypes. Particularly when
excluding no-calls, the TG array performance improved and the
Affymetrix array showed the highest discordance rate.
Conclusions
Because systematic differences between genotyping platforms can
lead to fallacious results in an association or linkage study, it is
important to evaluate the genotyping accuracy of various platforms.
To the best of our knowledge, this is the ﬁrst study which investigates
the performance of the TG array with other ready-made SNP chips.
The TG array showed high accordance and reasonable consistency
when comparedwith the Affymetrix and the Illumina arrayswhile the
Illumina array performed best. In conclusion, the TG array offers good
accuracy with the beneﬁt of ﬁnemapping with a high SNP density and
relatively low total costs for a selected area.
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